Global Hyaluronic Acid Market Research Report—Forecast till 2025
出 版 商：Market Research Future
出版日期：2020/12/01
頁 數：179頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Global Hyaluronic Acid Market: Information by Grade (Cosmetic Grade, Pharmaceutical Grade and Food Grade), By Application (Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Dietary Supplements, Ophthalmology and Others), By End User (Pharmaceutical Industry, Dermatology Clinics & Cosmetic Surgery Centers, Food Industry, Personal Care and Others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025
Market Analysis
Hyaluronic Acid Market is expected to register a CAGR of 7.02% to reach USD 18,153.6 Million by the year 2025. Hyaluronic acid is a glycosaminoglycan polymer commonly found in the extracellular matrix of vertebrate epithelial, connective, and neural tissues. It plays an important role in the many signaling pathways in the human body and useful in the treatment of joint and eye disorders, as well as plastic surgeries. Demand for a hyaluronic acid is increasing due to the increasing application of hyaluronic acid in cosmetic & personal care products and the increasing number of cosmetic surgeries. These factors are expected to fuel the growth of the global hyaluronic acid market. However, the availability of substitutes is expected to hinder market growth. Dermatologists inject hyaluronic acid-based fillers to make the skin appear firm. Botox and dermal filler treatments are popular, accounting for more than 9 million procedures in 2015, according to the American Society of Plastic Surgeons (ASPS). The use of hyaluronic acid dermal fillers is approved by the Food and Drug Administration (FDA). According to the International Society of Aesthetic Plastic Surgery (ISAPS), 465,296 modernization surgeries were performed in 2017, which grew by 9% in 2018. It is also used as a lip filler in plastic surgeries. According to the annual plastic surgery procedural statistics, there were 17.5 million surgical and minimally invasive cosmetic procedures performed in the US in the year 2017, a 2% increase over the year 2016. As per the American Society for Aesthetic Plastic Surgery (ASAPS), the use of hyaluronic acid injections increased by 58.4% in 2018, as compared to 2014. The organization also states that hyaluronic acid treatment was the second-leading non-surgical cosmetic procedure in 2018. Estimates that 810,240 hyaluronic acid procedures performed in 2018, after botulinum toxin in the Americas, with a outlay of nearly USD 544 million.
Market Segmentation
Global Hyaluronic Acid Market has been segmented by Grade, by Application, by End User and by End User. Based on Grade the Global Hyaluronic Acid Market has been segmented into cosmetic Grade, Pharmaceutical Grade and Food Grade. Based on Application the market has been segmented into Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Dietary Supplements, Ophthalmology and Others. Based on End User the Global Hyaluronic Acid Market has been segmented into Pharmaceutical Industry, Dermatology Clinics & Cosmetic Surgery Centers, Food Industry, Personal Care and Others. The dermatology clinics & cosmetic surgery centers held a share of 23.2% in the year 2018. Geographically the Global Hyaluronic Acid Market has been segmented into various different regions like Americas, Europe, Asia-Pacific, Middle East & Africa. Americas is sub- segmented into North America (US & Canada) and Latin America, Europe is sub-segmented into Western Europe (Germany, UK, France, Italy, Spain and Rest of Western Europe) and Eastern Europe. Asia-Pacific is sub-segmented into Japan, China, India, Australia, South Korea and Rest of Asia-Pacific, Middle East & Africa.
Regional Analysis
The global hyaluronic acid market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to dominate the global hyaluronic acid market. The growth in this region may be attributed to high demand for the product in the pharmaceutical industry. For example, the availability of a large pharmaceutical base in the US is a vital driver for the growth of the regional market. According to the European Federation of Pharmaceutical Industries & Association (EFPIA), North America accounted for 48.9% of world pharmaceutical sales in 2017. Moreover, the US invested nearly USD 55,755 million in pharmaceutical R&D expenditure, which exhibited an annual growth rate of 8.6%. Additionally, many important companies in the market are developing regional vendors to strengthen its position in the market. Europe held a share of 26.8% in the global hyaluronic acid market in 2018. This can be attributed to the increasing application of hyaluronic acid in cosmetic & personal care products. Asia-Pacific are estimated being the fastest-growing region in the global market. This is due to growing demand for hyaluronic acid and a growing number of cosmetic surgeries fueling the growth of the hyaluronic acid market in the region. The hyaluronic acid market in the Middle East & Africa is expected to witness steady growth during the review period due to limited access and healthcare affordability among the population. Growing awareness of hyaluronic acid is expected to drive market growth during the assessment period.
Major Players
Pharmaceutical companies, Contract research manufacturing organizations, Research & development organizations and Academic institutes are some of the projected on lookers for the Global Hyaluronic Acid Market. Allergan, Contipro AS, Symatese Group, Zhonglan Industry Co., Ltd, Altergon Italia SRL, Fidia Farmaceutici SPA, Bioiberica SAU, Kewpie Corporation, Seikagaku Corporation, and Anika Therapeutics are some of the major players in the Global Hyaluronic Acid Market are
Market Analysis
Hyaluronic Acid Market is expected to register a CAGR of 7.02% to reach USD 18,153.6 Million by the year 2025. Hyaluronic acid is a glycosaminoglycan polymer commonly found in the extracellular matrix of vertebrate epithelial, connective, and neural tissues. It plays an important role in the many signaling pathways in the human body and useful in the treatment of joint and eye disorders, as well as plastic surgeries. Demand for a hyaluronic acid is increasing due to the increasing application of hyaluronic acid in cosmetic & personal care products and the increasing number of cosmetic surgeries. These factors are expected to fuel the growth of the global hyaluronic acid market. However, the availability of substitutes is expected to hinder market growth. Dermatologists inject hyaluronic acid-based fillers to make the skin appear firm. Botox and dermal filler treatments are popular, accounting for more than 9 million procedures in 2015, according to the American Society of Plastic Surgeons (ASPS). The use of hyaluronic acid dermal fillers is approved by the Food and Drug Administration (FDA). According to the International Society of Aesthetic Plastic Surgery (ISAPS), 465,296 modernization surgeries were performed in 2017, which grew by 9% in 2018. It is also used as a lip filler in plastic surgeries. According to the annual plastic surgery procedural statistics, there were 17.5 million surgical and minimally invasive cosmetic procedures performed in the US in the year 2017, a 2% increase over the year 2016. As per the American Society for Aesthetic Plastic Surgery (ASAPS), the use of hyaluronic acid injections increased by 58.4% in 2018, as compared to 2014. The organization also states that hyaluronic acid treatment was the second-leading non-surgical cosmetic procedure in 2018. Estimates that 810,240 hyaluronic acid procedures performed in 2018, after botulinum toxin in the Americas, with a outlay of nearly USD 544 million.
Market Segmentation
Global Hyaluronic Acid Market has been segmented by Grade, by Application, by End User and by End User. Based on Grade the Global Hyaluronic Acid Market has been segmented into cosmetic Grade, Pharmaceutical Grade and Food Grade. Based on Application the market has been segmented into Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Dietary Supplements, Ophthalmology and Others. Based on End User the Global Hyaluronic Acid Market has been segmented into Pharmaceutical Industry, Dermatology Clinics & Cosmetic Surgery Centers, Food Industry, Personal Care and Others. The dermatology clinics & cosmetic surgery centers held a share of 23.2% in the year 2018. Geographically the Global Hyaluronic Acid Market has been segmented into various different regions like Americas, Europe, Asia-Pacific, Middle East & Africa. Americas is sub- segmented into North America (US & Canada) and Latin America, Europe is sub-segmented into Western Europe (Germany, UK, France, Italy, Spain and Rest of Western Europe) and Eastern Europe. Asia-Pacific is sub-segmented into Japan, China, India, Australia, South Korea and Rest of Asia-Pacific, Middle East & Africa.
Regional Analysis
The global hyaluronic acid market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to dominate the global hyaluronic acid market. The growth in this region may be attributed to high demand for the product in the pharmaceutical industry. For example, the availability of a large pharmaceutical base in the US is a vital driver for the growth of the regional market. According to the European Federation of Pharmaceutical Industries & Association (EFPIA), North America accounted for 48.9% of world pharmaceutical sales in 2017. Moreover, the US invested nearly USD 55,755 million in pharmaceutical R&D expenditure, which exhibited an annual growth rate of 8.6%. Additionally, many important companies in the market are developing regional vendors to strengthen its position in the market. Europe held a share of 26.8% in the global hyaluronic acid market in 2018. This can be attributed to the increasing application of hyaluronic acid in cosmetic & personal care products. Asia-Pacific are estimated being the fastest-growing region in the global market. This is due to growing demand for hyaluronic acid and a growing number of cosmetic surgeries fueling the growth of the hyaluronic acid market in the region. The hyaluronic acid market in the Middle East & Africa is expected to witness steady growth during the review period due to limited access and healthcare affordability among the population. Growing awareness of hyaluronic acid is expected to drive market growth during the assessment period.
Major Players
Pharmaceutical companies, Contract research manufacturing organizations, Research & development organizations and Academic institutes are some of the projected on lookers for the Global Hyaluronic Acid Market. Allergan, Contipro AS, Symatese Group, Zhonglan Industry Co., Ltd, Altergon Italia SRL, Fidia Farmaceutici SPA, Bioiberica SAU, Kewpie Corporation, Seikagaku Corporation, and Anika Therapeutics are some of the major players in the Global Hyaluronic Acid Market are
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVE ANALYSIS 19
1.1.1 GLOBAL HYALURONIC ACID MARKET, BY GRADE 19
1.1.2 GLOBAL HYALURONIC ACID, BY APPLICATION 20
1.1.3 GLOBAL HYALURONIC ACID, BY END USER 21
2 MARKET INTRODUCTION
2.1 DEFINITION 22
2.2 SCOPE OF THE STUDY 22
2.3 MARKET STRUCTURE 22
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 23
3.2 PRIMARY RESEARCH 24
3.3 SECONDARY RESEARCH 25
3.4 MARKET SIZE ESTIMATION 26
3.5 FORECAST MODEL 27
3.6 LIST OF ASSUMPTIONS 27
4 MARKET DYNAMICS
4.1 INTRODUCTION 28
4.2 DRIVERS 29
4.2.1 INCREASING APPLICATION OF HYALURONIC ACID IN COSMETIC & PERSONAL CARE PRODUCTS 29
4.2.2 INCREASING NUMBER OF COSMETIC SURGERIES 30
4.2.3 EXTENSIVE USE OF HYALURONIC ACID IN THE TREATMENT OF OSTEOARTHRITIS AND DRY EYE 31
4.3 RESTRAINTS 32
4.3.1 AVAILABILITY OF SUBSTITUTES 32
4.4 OPPORTUNITY 33
4.4.1 EXTENSIVE RESEARCH AND DEVELOPMENT ASSOCIATED WITH HYALURONIC ACID 33
4.5 TREND 34
4.5.1 USE OF HYALURONIC ACID AS AN ANIMAL SUPPLEMENT 34
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 35
5.1.1 RAW MATERIAL SUPPLIERS 35
5.1.2 HYALURONIC ACID PRODUCERS 36
5.1.3 DISTRIBUTION & SALES CHANNEL 36
5.1.4 END USERS 36
5.2 PORTER’S FIVE FORCES MODEL 37
5.2.1 THREAT OF NEW ENTRANTS 37
5.2.2 INTENSITY OF RIVALRY 38
5.2.3 THREAT OF SUBSTITUTES 38
5.2.4 BARGAINING POWER OF SUPPLIERS 38
5.2.5 BARGAINING POWER OF BUYERS 38
6 GLOBAL HYALURONIC ACID MARKET, BY GRADE
6.1 OVERVIEW 39
6.2 COSMETIC GRADE 41
6.3 PHARMACEUTICAL GRADE 41
6.4 FOOD GRADE 42
7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION
7.1 OVERVIEW 43
7.2 AESTHETICS 44
7.3 OSTEOARTHRITIS 45
7.4 PHARMACEUTICAL API 46
7.5 COSMETICS 46
7.6 DIETARY SUPPLEMENTS 47
7.7 OPHTHALMOLOGY 48
7.8 OTHERS 48
8 GLOBAL HYALURONIC ACID MARKET, BY END USER
8.1 OVERVIEW 49
8.2 PHARMACEUTICAL INDUSTRY 51
8.3 DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS 52
8.4 FOOD INDUSTRY 52
8.5 PERSONAL CARE 53
8.6 OTHERS 53
9 GLOBAL HYALURONIC ACID MARKET, BY REGION
9.1 OVERVIEW 54
9.2 NORTH AMERICA 57
9.2.1 US 61
9.2.2 CANADA 63
9.3 EUROPE 66
9.3.1 FRANCE 70
9.3.2 GERMANY 73
9.3.3 UK 75
9.3.4 SPAIN 78
9.3.5 ITALY 80
9.3.6 RUSSIA 83
9.3.7 BELGIUM 85
9.3.8 POLAND 88
9.3.9 REST OF EUROPE 90
9.4 ASIA-PACIFIC 93
9.4.1 CHINA 97
9.4.2 JAPAN 100
9.4.3 INDIA 102
9.4.4 SOUTH KOREA 105
9.4.5 AUSTRALIA 107
9.4.6 THAILAND 110
9.4.7 INDONESIA 112
9.4.8 REST OF ASIA-PACIFIC 115
9.5 LATIN AMERICA 118
9.5.1 BRAZIL 122
9.5.2 MEXICO 125
9.5.3 ARGENTINA 127
9.5.4 REST OF LATIN AMERICA 130
9.6 MIDDLE EAST & AFRICA 133
9.6.1 SAUDI ARABIA 137
9.6.2 UAE 140
9.6.3 TURKEY 142
9.6.4 SOUTH AFRICA 145
9.6.5 ISRAEL 147
9.6.6 REST OF MIDDLE EAST AND AFRICA 150
10 COMPETITIVE LANDSCAPE
10.1 COMPETITIVE OVERVIEW 153
10.2 GLOBAL MARKET STRATEGY ANALYSIS 153
10.3 KEY DEVELOPMENTS 153
10.4 COMPETITIVE BENCHMARKING 154
11 COMPANY PROFILES
11.1 ALLERGAN 155
11.1.1 COMPANY OVERVIEW 155
11.1.2 FINANCIAL OVERVIEW 156
11.1.3 PRODUCTS OFFERED 156
11.1.4 KEY DEVELOPMENTS 157
11.1.5 SWOT ANALYSIS 157
11.1.6 KEY STRATEGIES 157
11.2 CONTIPRO A.S. 158
11.2.1 COMPANY OVERVIEW 158
11.2.2 FINANCIAL OVERVIEW 158
11.2.3 PRODUCTS OFFERED 158
11.2.4 KEY DEVELOPMENTS 158
11.2.5 SWOT ANALYSIS 159
11.2.6 KEY STRATEGIES 159
11.3 SYMATESE GROUP 160
11.3.1 COMPANY OVERVIEW 160
11.3.2 FINANCIAL OVERVIEW 160
11.3.3 PRODUCTS OFFERED 160
11.3.4 KEY DEVELOPMENTS 160
11.3.5 SWOT ANALYSIS 161
11.3.6 KEY STRATEGIES 161
11.4 ZHONGLAN INDUSTRY CO., LTD 162
11.4.1 COMPANY OVERVIEW 162
11.4.2 FINANCIAL OVERVIEW 162
11.4.3 PRODUCTS OFFERED 162
11.4.4 KEY DEVELOPMENTS 162
11.4.5 SWOT ANALYSIS 163
11.4.6 KEY STRATEGIES 163
11.5 ALTERGON ITALIA SRL 164
11.5.1 COMPANY OVERVIEW 164
11.5.2 FINANCIAL OVERVIEW 164
11.5.3 PRODUCTS OFFERED 164
11.5.4 KEY DEVELOPMENTS 164
11.5.5 SWOT ANALYSIS 165
11.5.6 KEY STRATEGIES 165
11.6 FIDIA FARMACEUTICI S.P.A. 166
11.6.1 COMPANY OVERVIEW 166
11.6.2 FINANCIAL OVERVIEW 166
11.6.3 PRODUCTS OFFERED 166
11.6.4 KEY DEVELOPMENTS 166
11.6.5 SWOT ANALYSIS 167
11.6.6 KEY STRATEGIES 167
11.7 BIOIBERICA S.A.U. 168
11.7.1 COMPANY OVERVIEW 168
11.7.2 FINANCIAL OVERVIEW 168
11.7.3 PRODUCTS OFFERED 168
11.7.4 KEY DEVELOPMENTS 168
11.7.5 SWOT ANALYSIS 169
11.7.6 KEY STRATEGIES 169
11.8 KEWPIE CORPORATION 170
11.8.1 COMPANY OVERVIEW 170
11.8.2 FINANCIAL OVERVIEW 170
11.8.3 PRODUCTS OFFERED 171
11.8.4 KEY DEVELOPMENTS 171
11.8.5 SWOT ANALYSIS 171
11.8.6 KEY STRATEGIES 171
11.9 SEIKAGAKU CORPORATION 172
11.9.1 COMPANY OVERVIEW 172
11.9.2 FINANCIAL OVERVIEW 173
11.9.3 PRODUCTS OFFERED 173
11.9.4 KEY DEVELOPMENTS 174
11.9.5 SWOT ANALYSIS 174
11.9.6 KEY STRATEGIES 174
11.10 ANIKA THERAPEUTICS 175
11.10.1 COMPANY OVERVIEW 175
11.10.2 FINANCIAL OVERVIEW 175
11.10.3 PRODUCTS OFFERED 176
11.10.4 KEY DEVELOPMENTS 176
11.10.5 SWOT ANALYSIS 176
11.10.6 KEY STRATEGIES 176
12 APPENDIX
12.1 REFERENCES 177
12.2 RELATED REPORTS 178
1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVE ANALYSIS 19
1.1.1 GLOBAL HYALURONIC ACID MARKET, BY GRADE 19
1.1.2 GLOBAL HYALURONIC ACID, BY APPLICATION 20
1.1.3 GLOBAL HYALURONIC ACID, BY END USER 21
2 MARKET INTRODUCTION
2.1 DEFINITION 22
2.2 SCOPE OF THE STUDY 22
2.3 MARKET STRUCTURE 22
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 23
3.2 PRIMARY RESEARCH 24
3.3 SECONDARY RESEARCH 25
3.4 MARKET SIZE ESTIMATION 26
3.5 FORECAST MODEL 27
3.6 LIST OF ASSUMPTIONS 27
4 MARKET DYNAMICS
4.1 INTRODUCTION 28
4.2 DRIVERS 29
4.2.1 INCREASING APPLICATION OF HYALURONIC ACID IN COSMETIC & PERSONAL CARE PRODUCTS 29
4.2.2 INCREASING NUMBER OF COSMETIC SURGERIES 30
4.2.3 EXTENSIVE USE OF HYALURONIC ACID IN THE TREATMENT OF OSTEOARTHRITIS AND DRY EYE 31
4.3 RESTRAINTS 32
4.3.1 AVAILABILITY OF SUBSTITUTES 32
4.4 OPPORTUNITY 33
4.4.1 EXTENSIVE RESEARCH AND DEVELOPMENT ASSOCIATED WITH HYALURONIC ACID 33
4.5 TREND 34
4.5.1 USE OF HYALURONIC ACID AS AN ANIMAL SUPPLEMENT 34
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 35
5.1.1 RAW MATERIAL SUPPLIERS 35
5.1.2 HYALURONIC ACID PRODUCERS 36
5.1.3 DISTRIBUTION & SALES CHANNEL 36
5.1.4 END USERS 36
5.2 PORTER’S FIVE FORCES MODEL 37
5.2.1 THREAT OF NEW ENTRANTS 37
5.2.2 INTENSITY OF RIVALRY 38
5.2.3 THREAT OF SUBSTITUTES 38
5.2.4 BARGAINING POWER OF SUPPLIERS 38
5.2.5 BARGAINING POWER OF BUYERS 38
6 GLOBAL HYALURONIC ACID MARKET, BY GRADE
6.1 OVERVIEW 39
6.2 COSMETIC GRADE 41
6.3 PHARMACEUTICAL GRADE 41
6.4 FOOD GRADE 42
7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION
7.1 OVERVIEW 43
7.2 AESTHETICS 44
7.3 OSTEOARTHRITIS 45
7.4 PHARMACEUTICAL API 46
7.5 COSMETICS 46
7.6 DIETARY SUPPLEMENTS 47
7.7 OPHTHALMOLOGY 48
7.8 OTHERS 48
8 GLOBAL HYALURONIC ACID MARKET, BY END USER
8.1 OVERVIEW 49
8.2 PHARMACEUTICAL INDUSTRY 51
8.3 DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS 52
8.4 FOOD INDUSTRY 52
8.5 PERSONAL CARE 53
8.6 OTHERS 53
9 GLOBAL HYALURONIC ACID MARKET, BY REGION
9.1 OVERVIEW 54
9.2 NORTH AMERICA 57
9.2.1 US 61
9.2.2 CANADA 63
9.3 EUROPE 66
9.3.1 FRANCE 70
9.3.2 GERMANY 73
9.3.3 UK 75
9.3.4 SPAIN 78
9.3.5 ITALY 80
9.3.6 RUSSIA 83
9.3.7 BELGIUM 85
9.3.8 POLAND 88
9.3.9 REST OF EUROPE 90
9.4 ASIA-PACIFIC 93
9.4.1 CHINA 97
9.4.2 JAPAN 100
9.4.3 INDIA 102
9.4.4 SOUTH KOREA 105
9.4.5 AUSTRALIA 107
9.4.6 THAILAND 110
9.4.7 INDONESIA 112
9.4.8 REST OF ASIA-PACIFIC 115
9.5 LATIN AMERICA 118
9.5.1 BRAZIL 122
9.5.2 MEXICO 125
9.5.3 ARGENTINA 127
9.5.4 REST OF LATIN AMERICA 130
9.6 MIDDLE EAST & AFRICA 133
9.6.1 SAUDI ARABIA 137
9.6.2 UAE 140
9.6.3 TURKEY 142
9.6.4 SOUTH AFRICA 145
9.6.5 ISRAEL 147
9.6.6 REST OF MIDDLE EAST AND AFRICA 150
10 COMPETITIVE LANDSCAPE
10.1 COMPETITIVE OVERVIEW 153
10.2 GLOBAL MARKET STRATEGY ANALYSIS 153
10.3 KEY DEVELOPMENTS 153
10.4 COMPETITIVE BENCHMARKING 154
11 COMPANY PROFILES
11.1 ALLERGAN 155
11.1.1 COMPANY OVERVIEW 155
11.1.2 FINANCIAL OVERVIEW 156
11.1.3 PRODUCTS OFFERED 156
11.1.4 KEY DEVELOPMENTS 157
11.1.5 SWOT ANALYSIS 157
11.1.6 KEY STRATEGIES 157
11.2 CONTIPRO A.S. 158
11.2.1 COMPANY OVERVIEW 158
11.2.2 FINANCIAL OVERVIEW 158
11.2.3 PRODUCTS OFFERED 158
11.2.4 KEY DEVELOPMENTS 158
11.2.5 SWOT ANALYSIS 159
11.2.6 KEY STRATEGIES 159
11.3 SYMATESE GROUP 160
11.3.1 COMPANY OVERVIEW 160
11.3.2 FINANCIAL OVERVIEW 160
11.3.3 PRODUCTS OFFERED 160
11.3.4 KEY DEVELOPMENTS 160
11.3.5 SWOT ANALYSIS 161
11.3.6 KEY STRATEGIES 161
11.4 ZHONGLAN INDUSTRY CO., LTD 162
11.4.1 COMPANY OVERVIEW 162
11.4.2 FINANCIAL OVERVIEW 162
11.4.3 PRODUCTS OFFERED 162
11.4.4 KEY DEVELOPMENTS 162
11.4.5 SWOT ANALYSIS 163
11.4.6 KEY STRATEGIES 163
11.5 ALTERGON ITALIA SRL 164
11.5.1 COMPANY OVERVIEW 164
11.5.2 FINANCIAL OVERVIEW 164
11.5.3 PRODUCTS OFFERED 164
11.5.4 KEY DEVELOPMENTS 164
11.5.5 SWOT ANALYSIS 165
11.5.6 KEY STRATEGIES 165
11.6 FIDIA FARMACEUTICI S.P.A. 166
11.6.1 COMPANY OVERVIEW 166
11.6.2 FINANCIAL OVERVIEW 166
11.6.3 PRODUCTS OFFERED 166
11.6.4 KEY DEVELOPMENTS 166
11.6.5 SWOT ANALYSIS 167
11.6.6 KEY STRATEGIES 167
11.7 BIOIBERICA S.A.U. 168
11.7.1 COMPANY OVERVIEW 168
11.7.2 FINANCIAL OVERVIEW 168
11.7.3 PRODUCTS OFFERED 168
11.7.4 KEY DEVELOPMENTS 168
11.7.5 SWOT ANALYSIS 169
11.7.6 KEY STRATEGIES 169
11.8 KEWPIE CORPORATION 170
11.8.1 COMPANY OVERVIEW 170
11.8.2 FINANCIAL OVERVIEW 170
11.8.3 PRODUCTS OFFERED 171
11.8.4 KEY DEVELOPMENTS 171
11.8.5 SWOT ANALYSIS 171
11.8.6 KEY STRATEGIES 171
11.9 SEIKAGAKU CORPORATION 172
11.9.1 COMPANY OVERVIEW 172
11.9.2 FINANCIAL OVERVIEW 173
11.9.3 PRODUCTS OFFERED 173
11.9.4 KEY DEVELOPMENTS 174
11.9.5 SWOT ANALYSIS 174
11.9.6 KEY STRATEGIES 174
11.10 ANIKA THERAPEUTICS 175
11.10.1 COMPANY OVERVIEW 175
11.10.2 FINANCIAL OVERVIEW 175
11.10.3 PRODUCTS OFFERED 176
11.10.4 KEY DEVELOPMENTS 176
11.10.5 SWOT ANALYSIS 176
11.10.6 KEY STRATEGIES 176
12 APPENDIX
12.1 REFERENCES 177
12.2 RELATED REPORTS 178
